ArticleCureus2026
Refractory Bradycardia in the Late Phase of Necrotizing Pancreatitis: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ECG abnormalities are common in acute pancreatitis, yet clinically significant bradyarrhythmias are rarely reported and have been described mainly in the early phase of the disease. We report the case of a 76-year-old hypertensive male who developed severe acute post-endoscopic retrograde cholangiopancreatography pancreatitis, complicated by infected pancreatic necrosis requiring readmission to the intensive care unit on day 20. He was managed with CT-guided drainage and culture-directed antibiotics. In the fourth week of illness, he developed recurrent sinus bradycardia, at times triggered by vagal stimuli (nasogastric tube placement and posture change) and at times occurring spontaneously. On days 25 and 28, he developed severe bradycardia refractory to IV atropine, progressing to cardiac arrest on both occasions; each was managed with brief CPR and a 1 mg IV bolus of epinephrine, with return of spontaneous circulation. On day 30, a further arrest occurred and could not be reversed despite prolonged CPR. Throughout these episodes, serial ECGs showed sinus bradycardia without conduction block, cardiac enzymes and echocardiographic parameters remained unremarkable, electrolytes were within normal range, and inflammatory biomarkers were declining; these findings did not support an alternative reversible cause. We discuss the potential pathophysiological mechanisms underlying this presentation and suggest that life-threatening bradyarrhythmias may also arise in the late phase of necrotizing pancreatitis, raising the case for a low threshold for proactive, aggressive management of bradyarrhythmia in this setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.